Next Article in Journal
Cost-Effectiveness of Influenza Vaccination Strategies in Adults: Older Adults Aged ≥65 Years, Adults Aged 50–64 Years, and At-Risk Adults Aged 19–64 Years
Next Article in Special Issue
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
Previous Article in Journal
SARS-CoV-2 Vaccination and the Bridge between First and Fourth Dose: Where Are We?
Previous Article in Special Issue
Waning Humoral Response after COVID-19 mRNA Vaccination in Maintenance Dialysis Patients and Recovery after a Complementary Third Dose
 
 
Article

Article Versions Notes

Vaccines 2022, 10(3), 442; https://doi.org/10.3390/vaccines10030442
Action Date Notes Link
article xml file uploaded 14 March 2022 11:02 CET Original file -
article xml uploaded. 14 March 2022 11:02 CET Update -
article pdf uploaded. 14 March 2022 11:02 CET Version of Record https://www.mdpi.com/2076-393X/10/3/442/pdf-vor
article html file updated 14 March 2022 11:03 CET Original file -
article xml file uploaded 15 March 2022 11:16 CET Update -
article xml uploaded. 15 March 2022 11:16 CET Update -
article pdf uploaded. 15 March 2022 11:16 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/442/pdf-vor
article html file updated 15 March 2022 11:18 CET Update -
article xml file uploaded 22 March 2022 04:51 CET Update -
article xml uploaded. 22 March 2022 04:51 CET Update https://www.mdpi.com/2076-393X/10/3/442/xml
article pdf uploaded. 22 March 2022 04:51 CET Updated version of record https://www.mdpi.com/2076-393X/10/3/442/pdf
article html file updated 22 March 2022 04:53 CET Update -
article html file updated 1 August 2022 05:34 CEST Update https://www.mdpi.com/2076-393X/10/3/442/html
Back to TopTop